Verificando…
Traducido automáticamente. Dosis y advertencias: consulta el original en inglés. Leer en inglés
Inicio / Registrado en Nigeria / Labcin-500 Tablets

Labcin-500 Tablets

NAFDAC Reg. No. 04-6174 Estupefaciente

Registrado en NAFDAC. Registro activoAs of 31 October 2026 · synced automatically from official sources.
Producto
Labcin-500 Tablets
Número NAFDAC
04-6174
Principio activo
Erythromycin (Erythromycin Stearate)
Dosis
500 mg
Forma
Tablet
Fabricante
No Constan
Solicitante (titular)
Embassy Pharmaceutical and Chemicals Limited
Approved
10 Nov 2020
Estado
Inactive Ver en NAFDAC ↗
Registro válido hasta
9 Nov 2025
Alertas de la OMS
No se ha encontrado ninguno
Informes de la comunidad
Ninguno
Tiempos comprobados
0

Pero sobre el medicamento, Erythromycin: uses, dosage and brands worldwide

Lo que encontramos

  • Labcin-500 Tablets is on the NAFDAC register with an active registration (04-6174). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generado automáticamente a partir del registro NAFDAC, QUIÉN alerta y los datos de la comunidad a partir de hoy. Este no es un consejo médico. Siga siempre a su médico o farmacéutico.

How to use Labcin-500 Tablets

Lo que dice el prospecto oficial. Si te lo recetó un médico, sigue la receta. Si el prospecto de tu caja es distinto, manda el de tu caja.

Para quién es

Erythromycin Topical Solution USP, 2% is indicated for the topical treatment of acne vulgaris.

Cómo tomarlo y con qué frecuencia
  • Erythromycin Topical Solution USP, 2% should be applied over the affected areas twice a day (morning and evening) after the skin is thoroughly washed with warm water and soap and patted dry
  • Acne lesions on the face, neck, shoulders, chest, and back may be treated in this manner
  • This medication should be applied with applicator top
  • If fingertips are used, wash hands after application
  • Drying and peeling may be controlled by reducing the frequency of applications
Infancia
  • Safety and effectiveness of this product
  • In pediatric patients have not been established
While you are taking it
  • Patients using Erythromycin Topical Solution USP, 2% should receive the following information and instructions: 1
  • This medication is to be used as directed by the physician
  • It is for external use only
  • Avoid contact with the eyes, nose, mouth, and all mucous membranes. 2
  • This medication should not be used for any disorder other than that for which it was prescribed. 3
  • Patients should not use any other topical acne medication unless otherwise directed by their physician. 4
  • Patients should report to their physician any signs of local adverse reactions
Talk to a doctor first if

Erythromycin Topical Solution USP, 2% is contraindicated in those individuals who have shown hypersensitivity to any of its components.

Warnings

Pseudomembranous colitis has been reported with nearly all antibacterial agents, including erythromycin, and may range in severity from mild to life-threatening. Therefore, it is important to consider this diagnosis in patients who present with diarrhea subsequent to the administration of antibacterial agents. Treatment with antibacterial agents alters the normal flora of the colon and may permit overgrowth of clostridia. Studies indicate that a toxin produced by Clostridium difficile is one primary cause of “antibiotic-associated colitis”. After the diagnosis of pseudomembranous colitis has been established, therapeutic measures should be initiated. …

Posibles efectos secundarios

The following local adverse reactions have been reported occasionally: peeling, dryness, itching, erythema, and oiliness. Irritation of the eyes and tenderness of the skin have also been reported with topical use of erythromycin. Generalized urticarial reactions possibly related to the use of erythromycin, which required systemic steroid therapy have been reported.

Pregnancy and breastfeeding

Pregnancy: Teratogenic Effects: Pregnancy Category B - There was no evidence of teratogenicity or any other adverse effect on reproduction in female rats fed erythromycin base (up to 0.25% of diet) prior to and during mating, during gestation and through weaning of two successive litters. There are, however, no adequate and well-controlled studies in pregnant women. …

How to store it

Store in a dry place at 20 to 25°C (68 to 77°F) [see USP Controlled Room Temperature].

Si olvidas una dosis

Tómala en cuanto te acuerdes, salvo que falte poco para la siguiente. En ese caso, sáltate la olvidada. Nunca tomes dos dosis a la vez para compensar. Revisa tu prospecto, porque algunos medicamentos son distintos.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2024-10-11.

Label for erythromycin (erythromycin stearate), the active ingredient registered with NAFDAC.

Check your pack of Labcin-500 Tablets

Add the expiry date on your pack for a full Trust Score.

O haz fotos de la caja
Te quedan 3 verificaciones gratis hoy Fuentes oficiales: FDA de EE. UU. · EMA (UE) · NAFDAC · alertas de la OMS

About Labcin-500 Tablets

What is in Labcin-500 Tablets?

Labcin-500 Tablets contains Erythromycin (Erythromycin Stearate) (500 mg), as tablet, according to its NAFDAC registration record.

Is Labcin-500 Tablets registered with NAFDAC?

Yes. Labcin-500 Tablets is listed on the NAFDAC register under registration number 04-6174, and its registration is active as of 31 October 2026.

Has Labcin-500 Tablets been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Labcin-500 Tablets in our automatically synced alert list.

How can I check that my pack of Labcin-500 Tablets is genuine?

Run a free authenticity scan with the NAFDAC number 04-6174, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Labcin-500 Tablets?

Follow your prescription or the leaflet in your pack. The official label says: Erythromycin Topical Solution USP, 2% should be applied over the affected areas twice a day (morning and evening) after the skin is thoroughly washed with warm water and soap and patted dry. Acne lesions on the face, neck, shoulders, chest, and back may be treated in this manner. This medication should be applied with applicator top. If fingertips are used, wash hands after app…

What is Labcin-500 Tablets used for?

Erythromycin Topical Solution USP, 2% is indicated for the topical treatment of acne vulgaris. (Summarised from the official U.S. FDA label for erythromycin (erythromycin stearate). Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Labcin-500 Tablets? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.